Tag Archives: fungal meningitis outbreak

Featured Stories
New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

Crash on N.State Pkwy Kills Port Jefferson Station Man

Single-Car Crash on Northern State Parkway Kills Port Jefferson Station Man

A Port Jefferson Station man was killed on Wednesday due to a single-vehicle crash on the Northern State Parkway in Dix Hills. Police are investigating the accident, Newsday reports. According to Newsday, the 81-year-old man was driving a Nissan Altima west in the right lane, west of Exit 42. He ...

Read More

Do Vitamin Drinks Pose Health Risks?Do Vitamin Drinks Pose Health Risks?

Do Vitamin Drinks Pose Health Risks?

Scientists are concerned vitamin drinks are contributing to levels of vitamins and other nutrients that are not only unnecessary, but potentially harmful.

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

FDA lacked jurisdiction to enforce violations at NECC in the past, was slow to release inspection results

As the Food and Drug Administration aims to assert more authority in regulating drug compounding pharmacies like the one responsible for the deadly nationwide outbreak of fungal meningitis, details have emerged that the agency has previously tried to flex regulatory … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals | Tagged , , , |

Senators promise action to prevent the next fungal meningitis outbreak

Lawmakers on Capitol Hill have promised to update federal regulations, namely with the Food and Drug Administration, that would bring pharmaceutical drug compounding labs under the agency’s eye in the future in hopes of avoiding situations like the current deadly … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Product Recalls | Tagged , , |

Ameridose shares more than owners with embattled compounding center

Conditions at Ameridose, a Massachusetts-based pharmaceutical drug supplier that shares some of the same owners as the company tied to the deadly nationwide outbreak of fungal meningitis, are such that it can not guarantee the safety of any of the … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Product Recalls, Recalled Drugs | Tagged , |

Main threat of fungal meningitis passes, health officials warn victims not yet in the clear

The primary threat posed by contaminated epidural steroid injection that’s been linked to a nationwide outbreak of fungal meningitis has passed but those who received the drugs are not in the clear just yet. According to an ABC News report, … Continue reading

Posted in Pharmaceuticals | Tagged |

Stress, worry plague those injected with contaminated steroid drug

For the thousands who received a contaminated epidural steroid injection in the last few months, the next few days and weeks will be filled with worry and stress as they wonder if they’ll be the next victims in the deadly … Continue reading

Posted in Pharmaceuticals | Tagged |

Variety of lawsuits filed in response to fungal meningitis outbreak

The victims of the deadly fungal meningitis outbreak have already begun to seek justice for their injuries or if they’ve lost a loved one who received a contaminated epidural steroid injection. According to a Reuters report, victims have two choices … Continue reading

Posted in Defective Products, Legal News, Malpractice, Pharmaceuticals | Tagged |

Conditions inside New England Compounding Center conducive to contamination

The drug compounding lab likely responsible for the deadly nationwide outbreak of fungal meningitis ignored many safety protocols designed to ensure sterility of its products. According to a New York Times report this week, health officials in Massachusetts released a … Continue reading

Posted in Pharmaceuticals | Tagged |

Skepticism of company at center of fungal meningitis outbreak continues to grow

The company at the center of the deadly fungal meningitis outbreak has been under increased oversight since a 2006 inspection of its pharmacy labs discovered widespread deficiencies in protocols for manufacturing drugs. According to an AP report, New England Compounding … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , |

Questions, concerns mount against New England Compounding Center as fungal meningitis outbreak widens

Health officials across the country fear that many of the other compounded or mixed drugs leaving the pharmacies at New England Compounding Center may be just as contaminated as the epidural steroid drug that has caused a deadly nationwide outbreak … Continue reading

Posted in Pharmaceuticals | Tagged |

More Floridians affected by fungal meningitis outbreak, third death in state reported

Health officials in Florida have confirmed a third death in the state linked to the nationwide outbreak of fungal meningitis. According to a WESH-TV report in Orlando, Fla., Florida’s Dept. of Health said Wednesday that a third person who received … Continue reading

Posted in Pharmaceuticals | Tagged |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.